These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 31240364)

  • 1. 'Engagement' of patients and healthcare professionals in regulatory pharmacovigilance: establishing a conceptual and methodological framework.
    Brown P; Bahri P
    Eur J Clin Pharmacol; 2019 Sep; 75(9):1181-1192. PubMed ID: 31240364
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Systematising Pharmacovigilance Engagement of Patients, Healthcare Professionals and Regulators: A Practical Decision Guide Derived from the International Risk Governance Framework for Engagement Events and Discourse.
    Bahri P; Pariente A
    Drug Saf; 2021 Nov; 44(11):1193-1208. PubMed ID: 34528215
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Strengthening and rationalizing pharmacovigilance in the EU: where is Europe heading to? A review of the new EU legislation on pharmacovigilance.
    Borg JJ; Aislaitner G; Pirozynski M; Mifsud S
    Drug Saf; 2011 Mar; 34(3):187-97. PubMed ID: 21332243
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effective integration of pharmacovigilance systems at public health facilities in resource-limited settings: A qualitative study.
    Adenuga BA; Kibuule D; Bamitale KDS; Rennie TW
    Res Social Adm Pharm; 2020 Aug; 16(8):1111-1116. PubMed ID: 31812500
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Proposals for Engaging Patients and Healthcare Professionals in Risk Minimisation from an Analysis of Stakeholder Input to the EU Valproate Assessment Using the Novel Analysing Stakeholder Safety Engagement Tool (ASSET).
    Bahri P; Morales DR; Inoubli A; Dogné JM; Straus SMJM
    Drug Saf; 2021 Feb; 44(2):193-209. PubMed ID: 33125664
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of patient reporting of adverse drug reactions to the UK 'Yellow Card Scheme': literature review, descriptive and qualitative analyses, and questionnaire surveys.
    Avery AJ; Anderson C; Bond CM; Fortnum H; Gifford A; Hannaford PC; Hazell L; Krska J; Lee AJ; McLernon DJ; Murphy E; Shakir S; Watson MC
    Health Technol Assess; 2011 May; 15(20):1-234, iii-iv. PubMed ID: 21545758
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Knowledge and attitude of health-care professionals in hospitals towards pharmacovigilance in Saudi Arabia.
    Alshammari TM; Alamri KK; Ghawa YA; Alohali NF; Abualkol SA; Aljadhey HS
    Int J Clin Pharm; 2015 Dec; 37(6):1104-10. PubMed ID: 26216270
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Linked health data for pharmacovigilance in children: perceived legal and ethical issues for stakeholders and data guardians.
    Hopf YM; Bond CB; Francis JJ; Haughney J; Helms PJ
    BMJ Open; 2014 Feb; 4(2):e003875. PubMed ID: 24523422
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Knowledge of Adverse Drug Reaction Reporting and the Pharmacovigilance of Biological Medicines: A Survey of Healthcare Professionals in Ireland.
    O'Callaghan J; Griffin BT; Morris JM; Bermingham M
    BioDrugs; 2018 Jun; 32(3):267-280. PubMed ID: 29721705
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impact of training on Nigerian healthcare professionals' knowledge and practice of pharmacovigilance.
    Osakwe A; Oreagba I; Adewunmi AJ; Adekoya A; Fajolu I
    Int J Risk Saf Med; 2013; 25(4):219-27. PubMed ID: 24305560
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacovigilance in resource-limited countries.
    Olsson S; Pal SN; Dodoo A
    Expert Rev Clin Pharmacol; 2015; 8(4):449-60. PubMed ID: 26041035
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Matching safety to access: global actors and pharmacogovernance in Kenya- a case study.
    Moscou K; Kohler JC
    Global Health; 2017 Mar; 13(1):20. PubMed ID: 28335786
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Key pharmacovigilance stakeholders' experiences of direct patient reporting of adverse drug reactions and their prospects of future development in the European Union.
    Inácio P; Cavaco A; Allan E; Airaksinen M
    Public Health; 2018 Feb; 155():119-128. PubMed ID: 29346070
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Establishing a Framework for the Use of Social Media in Pharmacovigilance in Europe.
    Brosch S; de Ferran AM; Newbould V; Farkas D; Lengsavath M; Tregunno P
    Drug Saf; 2019 Aug; 42(8):921-930. PubMed ID: 30929141
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Reporting of adverse drug reactions in India: A review of the current scenario, obstacles and possible solutions.
    Mulchandani R; Kakkar AK
    Int J Risk Saf Med; 2019; 30(1):33-44. PubMed ID: 30175985
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bulgarian Experience with Adverse Drug Reaction Reports from Patients and Consumers - Retrospective Data-base Study.
    Getova VI; Georgiev SR; Stoimenova AH; Petkova-Georgieva ES
    Folia Med (Plovdiv); 2018 Sep; 60(3):447-453. PubMed ID: 30355838
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Promoting and Protecting Public Health: How the European Union Pharmacovigilance System Works.
    Santoro A; Genov G; Spooner A; Raine J; Arlett P
    Drug Saf; 2017 Oct; 40(10):855-869. PubMed ID: 28735357
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Medication safety knowledge, attitudes and practices among community pharmacists in Lebanon.
    Hajj A; Hallit S; Ramia E; Salameh P;
    Curr Med Res Opin; 2018 Jan; 34(1):149-156. PubMed ID: 28758813
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A review of the National pharmacovigilance system in Malta - implementing and operating a pharmacovigilance management system.
    Tanti A; Micallef B; Serracino-Inglott A; Borg JJ
    Expert Opin Drug Saf; 2017 Jan; 16(1):65-76. PubMed ID: 27732110
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impact of a pharmacist-driven pharmacovigilance system in a secondary hospital in the Gauteng Province of South Africa.
    Terblanche A; Meyer JC; Godman B; Summers RS
    Hosp Pract (1995); 2018 Oct; 46(4):221-228. PubMed ID: 30092683
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.